person · Reporting owner
Harrison Russell Joseph
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc.SNOA · Entity 8177 | Director | May 30, 2018 | June 02, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sonoma Pharmaceuticals, Inc.
Report date May 30, 2018 · Filed June 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 46,520 |
Reported balance
After 2018-05-30 transaction · row 1
1 source rowRow 1 · 2018-05-30 · Grant · Acquired 1,538 · Balance 46,520 F1: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2018 Filed Jun 2, 2018 00:30 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantCommon Stock, $0.0001 par value per share | 1,538 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-18-001579 · harrison_frm4.xml · nonDerivative · entry 1 Harrison Russell Joseph · CIK 0001592423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,520 F1 · price: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan. Read SEC document |
| March 01, 2018 Filed Mar 3, 2018 00:04 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantCommon Stock, $0.0001 par value per share | 1,691 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-18-000571 · harrison_f4-030118.xml · nonDerivative · entry 1 Harrison Russell Joseph · CIK 0001592423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,982 F1 · price: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 02:41 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantCommon Stock, $0.0001 par value per share | 17,211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-18-000038 · harrison_f4.xml · nonDerivative · entry 1 Harrison Russell Joseph · CIK 0001592423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,291 F1 · price: The stock was granted by the Issuer as a bonus for services and vests immediately. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 21:40 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantCommon Stock, $0.0001 par value per share | 14,130 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-17-003205 · harrison_f4.xml · nonDerivative · entry 1 Harrison Russell Joseph · CIK 0001592423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,080 F1 · price: The stock was granted by the Issuer as a quarterly retainer as well as an annual grant pursuant to the Non-Employee Director Compensation Plan. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 22:55 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantCommon Stock, $0.0001 par value per share | 1,045 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-17-002260 · harrison_f4.xml · nonDerivative · entry 1 Harrison Russell Joseph · CIK 0001592423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,950 F1 · price: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 12:30 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantCommon Stock, $0.0001 par value per share | 895 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-17-001458 · harrison_frm4.xml · nonDerivative · entry 1 Harrison Russell Joseph · CIK 0001592423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,905 F1 · price: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:06 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantCommon Stock, $0.0001 par value per share | 843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-17-000479 · harrison_f4.xml · nonDerivative · entry 2 Harrison Russell Joseph · CIK 0001592423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,010 F2 · price: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:06 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantCommon Stock, $0.0001 par value per share | 2,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-17-000479 · harrison_f4.xml · nonDerivative · entry 1 Harrison Russell Joseph · CIK 0001592423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,167 F1 · price: The stock was granted by the Issuer as an annual grant pursuant to the Non-Employee Director Compensation Plan. Read SEC document |
| November 29, 2016 Filed Nov 30, 2016 22:02 UTC | Sonoma Pharmaceuticals, Inc. OCLS · Entity 8177 | GrantCommon Stock, $0.0001 par value per share | 1,229 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-16-000815 · harrison_frm4.xml · nonDerivative · entry 1 Harrison Russell Joseph · CIK 0001592423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917 F1 · price: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.